This circular clearly states that no changes have been made to the existing guidelines regarding the availability or distribution of insulin drugs.
Strict Instructions to Pharmacies
RGHS has also instructed all affiliated pharmacies to continue providing insulin drugs to eligible RGHS beneficiaries as per the prevailing guidelines.
Strict Action for Breaking Rules
The circular also clarifies that if any pharmacy refuses to provide insulin citing alleged changes in RGHS guidelines, it will be taken seriously.
Furthermore, appropriate action will be taken against the concerned pharmacy for any unnecessary delay in distribution.
Copies Sent to Officials
Copies of this circular, issued by Dr. Nidhi Patel, Additional Chief Executive Officer of RGHS, have been sent to various RGHS officials, medical and policy branches, all affiliated hospitals and pharmacies, as well as the TPA company Vidal Health India.